Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|July 26, 2020
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent UpdatesAdriana Coricello, Francesco Mesiti, Antonio Lupia, et al.
International Journal of Molecular Sciences|December 3, 2020
In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty MealAnnalisa Maruca, Antonio Lupia, Roberta Rocca, et al.
Future Medicinal Chemistry|March 29, 2022
Identification of SET/EED dual binders as innovative PRC2 inhibitorsRaffaella Catalano, Annalisa Maruca, Roberta Rocca, et al.
Molecules (Basel, Switzerland)|September 23, 2020
Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom SpeciesAnnalisa Maruca, Federica Moraca, Roberta Rocca, et al.
European Journal of Medicinal Chemistry|January 25, 2021
4-Oxoquinolines and monoamine oxidase: When tautomerism mattersFrancesco Mesiti, Annalisa Maruca, Vera Silva, et al.
European Journal of Medicinal Chemistry|September 25, 2019
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquineRaffaella Catalano, Roberta Rocca, Giada Juli, et al.
Molecules (Basel, Switzerland)|December 1, 2020
Natural Products Extracted from Fungal Species as New Potential Anti-Cancer Drugs: A Structure-Based Drug Repurposing Approach Targeting HDAC7Annalisa Maruca, Roberta Rocca, Raffaella Catalano, et al.
Frontiers in Chemistry|May 5, 2018
The Mu.Ta.Lig. Chemotheca: A Community-Populated Molecular Database for Multi-Target Ligands Identification and Compound-RepurposingFrancesco Ortuso, Donatella Bagetta, Annalisa Maruca, et al.
Molecules (Basel, Switzerland)|May 10, 2020
Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase InhibitorsAnnalisa Maruca, Delia Lanzillotta, Roberta Rocca, et al.
European Journal of Medicinal Chemistry|March 27, 2022
Synthesis of 2H-Imidazo[2',1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutationsVincenzo Cilibrasi, Virginia Spanò, Roberta Bortolozzi, et al.
Pageof 3